NeuroMetrix Market Cap

NeuroMetrix has a market cap or net worth of $8.60 million as of April 24, 2024. Its market cap has decreased by -23.20% in one year.

Market Cap

8.60M

Enterprise Value

-9.15M

1-Year Change

-23.20%

Ranking

#5280

Market Cap Chart

Since July 22, 2004, NeuroMetrix's market cap has decreased from $93.50M to $8.60M, a decrease of -90.80%. That is a compound annual growth rate of -11.37%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2024	8.80M	-3.30%
Apr 22, 2024	9.10M	5.81%
Apr 19, 2024	8.60M	17.81%
Apr 18, 2024	7.30M	2.82%
Apr 17, 2024	7.10M	1.43%
Apr 16, 2024	7.00M	-
Apr 15, 2024	7.00M	-5.41%
Apr 12, 2024	7.40M	-2.63%
Apr 11, 2024	7.60M	4.11%
Apr 10, 2024	7.30M	-2.67%
Apr 9, 2024	7.50M	-
Apr 8, 2024	7.50M	-1.32%
Apr 5, 2024	7.60M	-2.56%
Apr 4, 2024	7.80M	2.63%
Apr 3, 2024	7.60M	-3.80%
Apr 2, 2024	7.90M	-2.47%
Apr 1, 2024	8.10M	-3.57%
Mar 28, 2024	8.40M	1.20%
Mar 27, 2024	8.30M	5.06%
Mar 26, 2024	7.90M	-2.47%
Mar 25, 2024	8.10M	-1.22%
Mar 22, 2024	8.20M	1.23%
Mar 21, 2024	8.10M	5.19%
Mar 20, 2024	7.70M	-1.28%
Mar 19, 2024	7.80M	1.30%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Moleculin Biotech	9.58M
Fresh2 Group	9.54M
Aeterna Zentaris	9.49M
Telesis Bio	9.49M
BioRestorative Therapies	9.34M
Longeveron	8.97M
Kazia Therapeutics	8.91M
Inhibikase Therapeutics	8.87M

Market Cap Rankings